Buscar resultados de ensayos clínicos

Patrocinado por

Clear Cell Renal Cell Carcinoma - 28 Studies Found

Estado Estudiar
Terminated Nombre del estudio: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Condición:
  • Hereditary Clear Cell Renal Cell Carcinoma
  • Kidney Cancer
    • <
    Fecha: 2008-08-01
    Intervenciones:
    • Drug: sorafenib tosylate 400mg
Completed Nombre del estudio: Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
Condición: Clear Cell Renal Cell Carcinoma
Fecha: 2005-09-12
Intervenciones:
  • Drug: Bevacizumab 10mg/kg IV i
Completed Nombre del estudio: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Condición:
  • Clear Cell Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer

    • Fecha: 2012-08-24
    Intervenciones:
    • Biological: Bevacizumab Given

Completed Nombre del estudio: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma
Condición:
  • ccRCC
  • RCC
  • Kidney Cancer

  • Fecha: 2014-11-14
    Intervenciones:
    • Drug: PART 1: PT2385 Tablets P
Recruiting Nombre del estudio: Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma
Condición: Clear Cell Renal Cell Carcinoma
Fecha: 2016-01-20
Intervenciones:
  • Drug: X4P-001 Continuous, oral
Completed Nombre del estudio: Investigating Patient Satisfaction With Oral Anti-Cancer Treatment
Condición: Clear Cell Renal Cell Carcinoma
Fecha: 2014-07-03
Completed Nombre del estudio: Value of Various Chemokines in the Detection and Follow up of RCC
Condición: Clear Cell Renal Cell Carcinoma
Fecha: 2013-10-30
Intervenciones: Other: patients with renal cell carcinoma Chemokines that may be elevated in patients with RCC
Completed Nombre del estudio: 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
Condición: Clear Cell Renal Cell Carcinoma
Fecha: 2013-01-08
Intervenciones: Drug: Dovitinib Patients will be treated with dovitinib (5
Completed Nombre del estudio: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer
Condición: Metastatic Clear Cell Renal Cell Carcinoma
Fecha: 2013-11-29
Intervenciones: Drug: Lu-177-DOTA-girentuximab Drug: In-111-DOTA-girentuxi
Terminated Nombre del estudio: Vandetanib to Treat Advanced Kidney Cancer
Condición: Advanced Clear Cell Renal Carcinoma
Fecha: 2011-06-11
Intervenciones: Drug: vandetanib Daily dose 300mg/day by mouth, 28 day cycle
<<< Previous | Next >>>